Publication

Whole-brain activation signatures of weight-lowering drugs

Molecular Metabolism 101171, 2021

Hansen HH, Perens J, Roostalu U, Skytte JL, Salinas CG, Barkholt P, Thorbek DD, Rigbolt KTG, Vrang N, Jelsing J, Hecksher-Sørensen J

Share this page

Resource Library

Related resources

Atheroprotective effects of semaglutide in the diet-induced obese Ldlr-/- mouse model of atherosclerosis

Nephroprotective effects of semaglutide in a mouse model of hypertension-accelerated diabetic kidney disease

Rapid gut growth but persistent delay in digestive function in the postnatal period of preterm pigs

A3907, a novel inhibitor of bile acid transport in the intestine and the kidney, improves markers of metabolic and hepatic pathology and reduces NAFLD activity score and fibrosis stage in a diet-induced and biopsy-confirmed mouse model of nonalcoholic steatohepatitis

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650